top of page
< Back

GMP: Key differences US and EU

GMP compliance for EU and FDA

The United States and the European Union have their own regulatory frameworks for medical devices, which include Good Manufacturing Practices (GMP) requirements. While there are similarities between the two, there are also some key differences. Here's a comparison of the USA and EU GMP for medical devices:

1. Regulatory Authority:

- USA: The Food and Drug Administration (FDA) is responsible for regulating medical devices in the United States.

- EU: The European Union's medical device regulations are overseen by the European Medicines Agency (EMA) and the European Commission.

2. Scope and Definitions:

- USA: The FDA defines medical devices broadly and classifies them into three classes (Class I, II, and III) based on their potential risks to patients.

- EU: The EU has a broader definition of medical devices and classifies them into four classes (Class I, IIa, IIb, and III) based on risk and intended use.

3. Pre-Market Approval:

- USA: In the United States, the pre-market approval process varies depending on the device class. Class I devices generally do not require FDA approval, while Class II and III devices typically require 510(k) clearance or pre-market approval (PMA) respectively.

- EU: The EU requires a conformity assessment for medical devices, which involves a conformity assessment procedure based on the device's classification. The higher the risk class, the more involvement of a Notified Body is required.

4. Quality Management System (QMS):

- USA: The FDA's Quality System Regulation (QSR) outlines the requirements for establishing and maintaining a QMS for medical devices, known as 21 CFR Part 820.

- EU: The EU's Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) specify the requirements for manufacturers to have a QMS in place, which includes conformity to ISO 13485 standard.

5. Post-Market Surveillance:

- USA: The FDA monitors the safety and effectiveness of medical devices through various post-market surveillance activities, including adverse event reporting, inspections, and recalls.

- EU: The EU requires manufacturers to establish a post-market surveillance system to collect and analyze data on the performance and safety of their devices. They also have the Unique Device Identification (UDI) system in place for traceability.

6. Labeling and Language Requirements:

- USA: The FDA requires labeling to be in English and provides guidelines on the content and format of labeling materials.

- EU: The EU requires labeling to be in the official language(s) of the Member State(s) where the device is marketed, and it should include specific information as outlined in the regulations.

It's important to note that these comparisons provide a general overview, and specific requirements may vary depending on the type and classification of the medical device. Manufacturers seeking to market their devices in both the USA and the EU should thoroughly familiarize themselves with the respective GMP regulations to ensure compliance.

Check our services to go to the Market in USA and EU!

GMP: Key differences US and EU
bottom of page